Open access · CC-BY
via OpenAlex
The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
Caroline Merckx, Boél De Paepe
Metabolites · 2022 · ▲ 39 citations
Abstract
Taurine (2-aminoethanesulfonic acid) is required for ensuring proper muscle functioning. Knockout of the taurine transporter in mice results in low taurine concentrations in the muscle and associates with myofiber necrosis and diminished exercise capacity. Interestingly, regulation of taurine and its transporter is altered in the mdx mouse, a model for Duchenne Muscular Dystrophy (DMD). DMD is a genetic disorder characterized by progressive muscle degeneration and weakness due to the absence of dystrophin from the muscle membrane, causing destabilization and contraction-induced muscle cell damage. This review explores the physiological role of taurine in skeletal muscle and the consequences of a disturbed balance in DMD. Its potential as a supportive treatment for DMD is also discussed. In addition to genetic correction, that is currently under development as a curative treatment, taurine supplementation has the potential to reduce muscle inflammation and improve muscle strength in patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/metabo12020193
- Canonical
- link ↗
- Fetched
- 2026-08-03 MST
Cite this
APA
Merckx, C., & Paepe, B.D. (2022). The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy. <em>Metabolites</em>. https://doi.org/10.3390/metabo12020193
Vancouver
Merckx C, Paepe BD. The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy. Metabolites. 2022. doi:10.3390/metabo12020193.
BibTeX
@article{caroline2022TheRol,
title = {The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy},
author = {Caroline Merckx and Boél De Paepe},
journal = {Metabolites},
year = {2022},
doi = {10.3390/metabo12020193},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2017
Open access · CC-BY
Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction
Redox Biology 2016
Open access · CC-BY
Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy
The Analyst 2020
Preprint · OA
Investigation of the effect of taurine supplementation on muscle taurine content in the mdx mouse model of Duchenne muscular dystrophy using chemically specific synchrotron imaging
The Journal of veterinary medical science 2026
Open access · OA
Beta-nicotinamide mononucleotide attenuates creatine kinase release in Duchenne muscular dystrophy model rats.
Cellular and Molecular Life Sciences 2022
Open access · CC-BY
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Journal of Biomedical Science 2010
Open access · CC-BY